Ziyi He, Chenxi Wang, Huichuan Tian. "Letter by He et al Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”." Circulation, 2025. doi:10.1161/circulationaha.124.073256